Released: ·Last reviewed: ·Methodology v4.1
About Transparent Peptide
Transparent Peptide evaluates U.S. telehealth programs offering GLP-1 medications, peptide therapies and longevity treatments using a published, source-based methodology.
Our mission
Transparent Peptide helps people compare telehealth programs for GLP-1 medications, peptide therapies and longevity treatments. We evaluate total cost, clinician oversight, pharmacy disclosure, medication sourcing, patient support and plan terms — and we publish the evidence behind every score so readers can check our work.
Independence and affiliation
Transparent Peptide is not fully independent, and we say so plainly. Transparent Peptide is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. The affiliate disclosure appears in the footer of every page, and the publisher’s relationship with NexLife is described on the conflicts-of-interest page. See our conflicts-of-interest policy.
How we work
Every provider is scored under a published methodology before rankings are written. Facts are captured with dates and verification status. A physician and a nurse practitioner review clinical content. Corrections are logged.
Contact
Editorial: editorial@transparrentpeptide.com. Corrections: corrections@transparrentpeptide.com. See our contact page.